Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Pink Dx is an early-stage biotechnology company focused on improving women's health by developing innovative diagnostic solutions for gynecological cancers. The company aims to address the…

Pink Dx is an early-stage biotechnology company focused on improving women's health by developing innovative diagnostic solutions for gynecological cancers. The company aims to address the…
Stage & Funding: Series A — $45,000,000 total (initial $40M; $5M second close)
Focus: Early-stage women's health diagnostics, initial focus on gynecological cancers
Approach: Build clinical cohorts and apply bioinformatics & machine learning to develop non‑invasive tests
Headquarters: Daly City, California (USA)
Leadership: Bonnie Anderson (Co‑founder, CEO & Chair); Giulia Kennedy, Ph.D. (Co‑founder, CSO); Tim McMeekan (Co‑founder, CFO)
Women's health diagnostics (initial focus: gynecological cancers and unclear symptom presentations such as bloating, pelvic pain, abnormal bleeding).
2022
Biotechnology
$40,000,000
Initial announced Series A at public launch.
$5,000,000
Second close added new investors including Blue Venture Fund, Sandbox Clinical Ventures, and BEVC; brings reported total in the upsized Series A to $45,000,000.
“Backed by venture and strategic healthcare investors including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic, Blue Venture Fund, Sandbox Clinical Ventures, and BEVC.”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week